Moreover, expression levels of miR-152 were found to be dysregulated in ovarian cancer in previous studies (Li et al. 2018; Zhou et al. 2012; Qin et al. 2018), indicating a potential role of HCG18 in ovarian cancer. The gene discussed is HCG18; the disease is ovarian carcinoma.